<DOC>
	<DOCNO>NCT00377975</DOCNO>
	<brief_summary>This study compare four treatment see one cause weight loss , fat loss , loss abdominal fat improvement blood test like cholesterol . The four treatment : Placebo , Ephedrine plus caffeine , Pioglitazone , Combined pioglitazone ephedrine plus caffeine</brief_summary>
	<brief_title>`` Pecos '' B-adrenergic PPAR-G Stimulation Upregulates Lipid Metabolism Human Subcutaneous Fat</brief_title>
	<detailed_description>The sympathetic nervous system , via intracellular messenger cAMP MAPK activation , thiazolidinediones via PPARÎ³ control lipid metabolism implicate body weight regulation . The present study undertaken determine whether simultaneous activation two signal system might synergize exert beneficial effect expression key gene involve lipid metabolism mitochondrial biogenesis subcutaneous fat healthy , non-diabetic subject . Fifty seven non-diabetic woman men randomize four group : 1 ) placebo/placebo ( PP ) ; 2 ) ephedrine plus caffeine/placebo ( ECP ) ; 3 ) placebo/pioglitazone ( PPio ) ; 4 ) ephedrine plus caffeine/pioglitazone ( ECPio ) . Adipose tissue sample obtain 12 week treatment determine gene expression real time RT-PCR .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>generally healthy pregnant nursing use adequate contraception 18 50 year age BMI 30 35 kg/m2 significant renal , cardiac , liver , lung neurological disease high blood pressure diabetes prior use thiazolidinedione prior use betablockers alcohol drug abuse history thrombophlebitis , vascular blood clot disorder unwilling unable abstain caffeinated beverage alcohol prior adipose tissue biopsy metabolic rate measurement increase liver function test baseline metal object would interfere measurement body composition use drug know affect lipid metabolism , energy metabolism body weight use herbal supplement contain ephedrine and/or caffeine take chronic medication , except hormone replacement contraception woman unwilling use effective contraception trial heart disease history stroke urinary symptom enlarge prostate gain lose 10 pound last 6 month use monoamine oxidase inhibitor medication last month high low thyroid function control normal range least 2 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>UCP-1</keyword>
	<keyword>ephedrine</keyword>
	<keyword>caffeine</keyword>
	<keyword>pioglitazone</keyword>
</DOC>